“Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review” (2025) Molecular Medicine Communications, 5(1), pp. 17–28. doi:10.55627/mmc.005.01.01795.